External funding opportunities
On this page, EB-ResNet provides information on external funding possibilities. We do not intend to give a complete overview of funding possibilities but display interesting calls and information about other funding sources relevant for persons involved in EB research.
Upcoming and current external calls
INNOVATIVE MEDICINES INITIATIVE: IMI-2 - Call 23
Topic 5: Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies
Deadlines
Stage 1 submission deadline: 29 September 2020
Stage 2 submission deadline: 17 March 2021
More Information
Visit the IMI2 – Call 23 Website.
Watch the recording of the Webinar.
Use the „Partner Search“ Tool on the EC Funding & Tenders Website in order to find an existing consortium looking for partners and/or to offer your expertise by adding a small abstract of your institute and expertise!
More Information
FFG - Austrian Research Promotion Agency
Dr. Astrid Hoebertz: astrid.hoebertz@ffg.at
FIRTZ THYSSEN FOUNDATION: Support of Research in Medicine and Natural Sciences
The Fritz Thyssen Foundation supports research in Medicine and Natural Sciences that have a clear connection to the German research system. This connection can be established either
- at a personal level through German scientists working on the project
- at an institutional level through non-German scientists being affiliated to German research institutes
- or through studies on topics related thematically to German research interests
Deadline 15th February 2021
Deadline 30th November 2020
Submission anytime
Submission anytime
Application
Applications may be submitted in German or in English by mail and e-mail.
Contact
Petra Kehde
Phone: +49.221.277496-184
petra.kehde@fritz-thyssen-stiftung.de
ALMIRALL SHARE: Collaboration Opportunities
1. Innovative Therapies for skin diseases
Maximising the value of your preclinical assets to find a breakthrough therapy for patients.
Deadline: 31 October 2020
Scope
AlmirallShare is looking for partnering opportunities on new assets at advanced Research or preclinical Development stage.
The proposed asset should demonstrate a scientific rationale and therapeutic potential for treating dermatological conditions.
Share your idea if it does not fit with current initiatives of AlmirallShare.
Submit proposal at any time
Eligibility and Application
Scientists affiliated to start-ups, biotechs, universities, research centres, and pharmaceutical companies all over the world.
Create an account in AlmirallShare Innovation platform.
More information and Contact
